PLRX
Pliant Therapeutics Inc
Price:  
14.52 
USD
Volume:  
338,093.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PLRX WACC - Weighted Average Cost of Capital

The WACC of Pliant Therapeutics Inc (PLRX) is 7.3%.

The Cost of Equity of Pliant Therapeutics Inc (PLRX) is 7.25%.
The Cost of Debt of Pliant Therapeutics Inc (PLRX) is 7.00%.

Range Selected
Cost of equity 6.00% - 8.50% 7.25%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.0% - 8.5% 7.3%
WACC

PLRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.47 0.66
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.00% 8.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.01 0.01
Cost of debt 7.00% 7.00%
After-tax WACC 6.0% 8.5%
Selected WACC 7.3%